Patents Assigned to Immune Control, Inc.
  • Compositions for treatment of diseases related to activated lymphocytes
    Patent number: 7981885
    Abstract: The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: July 19, 2011
    Assignee: Immune Control Inc.
    Inventors: Stephen Roth, Clayton Buck, Christopher Self, Gary Olson
  • Methods for treatment of diseases related to activated lymphocytes
    Patent number: 7923445
    Abstract: The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: April 12, 2011
    Assignee: Immune Control, Inc.
    Inventors: Stephen Roth, Clayton Buck, Christopher Self, Gary Olson
  • Novel Composition for Treatment of Diseases Related to Activated Lymphocytes
    Publication number: 20090275557
    Abstract: The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.
    Type: Application
    Filed: February 26, 2009
    Publication date: November 5, 2009
    Applicant: Immune Control, Inc.
    Inventors: Stephen Roth, Clayton Buck, Christopher Self, Gary Olson, Nallaganchu Rao
  • Novel compositions for treatment of diseases related to activated lymphocytes
    Publication number: 20080132697
    Abstract: The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.
    Type: Application
    Filed: August 31, 2007
    Publication date: June 5, 2008
    Applicant: Immune Control, Inc.
    Inventors: Stephen Roth, Clayton Buck, Christopher Self, Gary Olson
  • Novel methods for treatment of diseases related to activated lymphocytes
    Publication number: 20080125415
    Abstract: The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.
    Type: Application
    Filed: August 31, 2007
    Publication date: May 29, 2008
    Applicant: Immune Control, Inc.
    Inventors: Stephen Roth, Clayton Buck, Christopher Self, Gary Olson